James R. Empfield
CIK 1665430 · View on SEC EDGAR ↗
Insider
First SEC filing: Feb. 9, 2016 · Latest: Feb. 9, 2016
On this page
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 24 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
24 other filings hidden
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 12, 2022 | XENE | S | 21,875 | $38.68 | $846,125 | 10,000 Direct | -68.63% | Disposed | 65.3% (price as of 2026-08-19) |
| Aug. 12, 2022 | XENE | S | 35,868 | $38.08 | $1,365,853 | 31,875 Direct | -52.95% | Disposed | 67.9% (price as of 2026-08-19) |
| March 7, 2022 | XENE | S | 31,048 | $30.54 | $948,206 | 10,000 Direct | -75.64% | Disposed | 109.4% (price as of 2026-08-19) |
| March 7, 2022 | XENE | S | 1,805 | $30.62 | $55,269 | 41,048 Direct | -4.21% | Disposed | 108.9% (price as of 2026-08-19) |
| March 4, 2022 | XENE | S | 18,315 | $30.79 | $563,919 | 10,000 Direct | -64.68% | Disposed | 107.7% (price as of 2026-08-19) |
| Aug. 15, 2017 | XENE | P | 10,000 | $2.48 | $24,800 | 10,000 Direct | — | Acquired | 2478.6% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 11, 2024 | XENE | Stock Option (Right to Buy) | Common Shares (65,000) | $44.37 | March 10, 2034 | 65,000 | Acquired |
| March 10, 2023 | XENE | Stock Option (Right to Buy) | Common Shares (75,000) | $34.18 | March 9, 2033 | 75,000 | Acquired |
| Aug. 12, 2022 | XENE | Stock Option (Right to Buy) | Common Shares (45,000) | $4.75 | March 11, 2028 | 45,000 | Disposed |
| Aug. 12, 2022 | XENE | Stock Option (Right to Buy) | Common Shares (20,000) | $3.10 | Oct. 22, 2027 | 20,000 | Disposed |
| March 10, 2022 | XENE | Stock Option (Right to Buy) | Common Shares (65,000) | $30.01 | March 9, 2032 | 65,000 | Acquired |
| March 7, 2022 | XENE | Stock Option (Right to Buy) | Common Shares (40,000) | $6.76 | Feb. 7, 2026 | 40,000 | Disposed |
| March 7, 2022 | XENE | Stock Option (Right to Buy) | Common Shares (2,500) | $8.40 | March 12, 2027 | 2,500 | Disposed |
| March 4, 2022 | XENE | Stock Option (Right to Buy) | Common Shares (25,000) | $8.40 | March 12, 2027 | 25,000 | Disposed |
| March 12, 2021 | XENE | Stock Option (Right to Buy) | Common Shares (65,000) | $20.55 | March 11, 2031 | 65,000 | Acquired |
| March 12, 2020 | XENE | Stock Option (Right to Buy) | Common Shares (65,000) | $11.58 | March 11, 2030 | 65,000 | Acquired |
| Sept. 16, 2019 | XENE | Stock Option (Right to Buy) | Common Shares (40,000) | $9.44 | Sept. 15, 2029 | 40,000 | Acquired |
| March 12, 2018 | XENE | Stock Option (Right to Buy) | Common Shares (45,000) | $4.75 | March 11, 2028 | 45,000 | Acquired |
| Oct. 23, 2017 | XENE | Stock Option (Right to Buy) | Common Shares (20,000) | $3.10 | Oct. 22, 2027 | 20,000 | Acquired |
| March 13, 2017 | XENE | Stock Option (Right to Buy) | Common Shares (27,500) | $8.40 | March 12, 2027 | 27,500 | Acquired |
| Feb. 8, 2016 | XENE | Stock Option (Right to Buy) | Common Shares (40,000) | $6.76 | Feb. 7, 2026 | 40,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.